Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 6 , Pages 470-478 , November 2009

The existence of cognitive plateaus in Alzheimer's disease

  • Andrea C. Bozoki

      Affiliations

    • Department of Neurology, Michigan State University, East Lansing, MI, USA
    • Corresponding Author InformationCorresponding author. Tel.: 517-884-2482; Fax: 517-432-9414.
  • ,
  • Hyonggin An

      Affiliations

    • Department of Biostatistics, College of Medicine, Korea University, Seoul, Korea
  • ,
  • Eva S. Bozoki

      Affiliations

    • Brookhaven National Laboratories, Upton, NY, USA (retired)
  • ,
  • Roderick J. Little

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA

References 

  1. Haxby VJ, Raffaele K, Gillette J, Schapiro BM, Rapoport IS. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol. 1992;14:575–592
  2. Helmes E, Merskey H, Fox H, Fry RN, Bowler JV, Hachinski VC. Patterns of deterioration in senile dementia of the Alzheimer type. Arch Neurol. 1995;52:306–310
  3. Piccini C, Bracco L, Falcini M, Pracucci G, Amaducci L. Natural history of Alzheimer's disease: prognostic value of plateaux. Neurol Sci. 1995;131:177–182
  4. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1976;12:189–198
  5. Kazman R, Brown T, Thal LJ, Fuld PA, Aronson M, Butters N, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol. 1988;24:384–389
  6. Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB. Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol. 1995;50(A):49–55
  7. Yesavage JA, Poulsen SL, Sheikh J, Tanke E. Rates of change of common measures of impairment in senile dementia of the Alzheimer type. Psychopharmacol Bull. 1988;24:531–534
  8. Han L, Cole M, Bellavance F, McCusker J, Primeau F. Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: a meta-analysis. Int Psychogeriatr. 2000;12:231–247
  9. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics. 1982;38:963–974
  10. Jacqmin-Gadda H, Fabrigoule C, Commenges D, Dartigues JF. A 5-year longitudinal study of the Mini-Mental State Examination in Normal Aging. Am J Epidemiol. 1997;145:498–506
  11. Brooks JO, Kraemer HC, Tanke ED, Yesavage JA. The methodology of studying decline in Alzheimer's disease. J Am Geriatr Soc. 1993;41:623–628
  12. Helmes E, Merskey H, Fox H, Bowler JV, Hachinski VC. Profiles of cognitive decline in Alzheimer disease. Alzheimer Dis Assoc Disord. 2002;16:123–127
  13. Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Individual growth curve analysis of ApoE e4-associated cognitive decline in Alzheimer disease. Arch Neurol. 2005;62:454–459
  14. Smith GE, Pankratz VS, Negash S, Machulda MM, Petersen RC, Boeve BF, et al. A plateau in pre-Alzheimer memory decline. Neurology. 2007;69:133–139
  15. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part V—a normative study of the neuropsychological battery. Neurology. 1994;44:609–614
  16. Heyman A, Peterson B, Fillenbaum G, Pieper C. The consortium to establish a registry for Alzheimer's disease (CERAD): part XIV—demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology. 1996;46:656–660
  17. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to establish a registry for Alzheimer's disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159–1165
  18. Cattel C, Gambassi G, Sgadari A, Zuccalà G, Carbonin P, Bernabei R. Correlates of delayed referral for the diagnosis of dementia in an outpatient population. J Gerontol A Biol Sci Med Sci. 2000;55:M98–M102
  19. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The consortium to establish a registry for Alzheimer's disease (CERAD): part IV—rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993;43:2457–2465
  20. Suh GH, Ju YS, Yeon BK, Shah A. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline. Int J Geriatr Psychiatry. 2004;19:817–824
  21. Hall CB, Derby C, LeValley A, Katz MJ, Verghese J, Lipton RB. Education delays accelerated decline on a memory test in persons who develop dementia. Neurology. 2007;69:1657–1664
  22. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education: the Rotterdam study. Br Med J. 1995;310:970–973
  23. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology. 1995;45:1707–1712
  24. Mirra SS. Neuropathological assessment of Alzheimer's disease: the experience of the Consortium to Establish a Registry for Alzheimer's Disease. Int Psychogeriatr. 1997;9(Suppl 1):263–268
  25. Atri A, Shaughnessy LW, Locascio JJ, Growdon JH. Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22:209–221

PII: S1552-5260(09)02030-5

doi: 10.1016/j.jalz.2009.05.669

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 6 , Pages 470-478 , November 2009